Description

Cyclohexanecarboxylic acid, 1-((1,3,3a,4,7,7a-hexahydro-1,3-dioxo-4,7- methano-2H-isoindol-2-2-yl)methyl)-2-(4-(2-pyridinyl)-1-piperazinyl)et hyl ester, (Z)-2-butenedioate (1:2) is a complex organic salt with a defined molecular architecture. This compound is significant for its role as a key synthetic intermediate or active pharmaceutical ingredient (API) in advanced research and development. It is primarily required by pharmaceutical, agrochemical, and specialty chemical manufacturers engaged in the synthesis of novel therapeutic agents or high-value fine chemicals.

Application

• Pharmaceutical Intermediate: Serves as a critical building block in the synthesis of novel drug candidates, particularly in central nervous system (CNS) or cardiovascular research.
• Agrochemical Research: Used in the development of new active ingredients for crop protection products, leveraging its complex heterocyclic structure.
• Chemical Synthesis: Acts as a versatile precursor for creating specialized ligands, catalysts, or other complex organic molecules in laboratory settings.
• Biochemical Research: Potential application in biochemical assays or as a tool compound for studying specific biological pathways and receptor interactions.
• Material Science: May be investigated for the development of advanced polymers or specialty coatings with unique properties.

Basic Information

Product Name	Cyclohexanecarboxylic acid, 1-((1,3,3a,4,7,7a-hexahydro-1,3-dioxo-4,7- methano-2H-isoindol-2-2-yl)methyl)-2-(4-(2-pyridinyl)-1-piperazinyl)et hyl ester, (Z)-2-butenedioate (1:2)
CAS No.	84916-44-9
Molecular Formula	Contact for details
Molecular Weight	Contact for details
Synonyms	1-[(1,3,3a,4,7,7a-Hexahydro-1,3-dioxo-4,7-methano-2H-isoindol-2-yl)methyl]-2-[4-(2-pyridinyl)-1-piperazinyl]ethyl cyclohexanecarboxylate (Z)-2-butenedioate (1:2); Cyclohexanecarboxylic acid, 1-((hexahydro-1,3-dioxo-4,7-methano-2H-isoindol-2-yl)methyl)-2-(4-(2-pyridinyl)-1-piperazinyl)ethyl ester, (Z)-2-butenedioate (2:1); Fumarate salt of a cyclohexanecarboxylate-piperazinyl derivative; 84916-44-9; UNII-Contact for details
EINECS	Contact for details

Quality Control

Our products undergo rigorous quality testing to ensure compliance with industry standards. We implement strict in-process controls and final release testing, which typically includes identification, assay, and impurity profiling. Certificates of Analysis (COA) detailing purity, related substances, and other critical parameters are available upon request. Production can be aligned with cGMP guidelines for pharmaceutical applications.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at controlled room temperature (15-25°C). Due to its hygroscopic (moisture-sensitive) nature, the container must be kept tightly sealed to prevent degradation from atmospheric moisture. Keep away from incompatible materials.

Specification

Item	Specification
Appearance	White to off-white solid
Identification (IR)	Conforms to reference spectrum
Identification (HPLC)	Retention time matches reference standard
Assay (HPLC)	≥ 98.0%
Related Substances (HPLC)	Total impurities ≤ 2.0% Any single impurity ≤ 1.0%
Water Content (KF)	≤ 1.0%
Residue on Ignition	≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.